Temporin-1Sa [S3K,F13L], SEQ ID NO:5 for Patent EP 2853538 A1

General Information


DRACP ID  DRACP02404

Peptide Name   Temporin-1Sa [S3K,F13L], SEQ ID NO:5 for Patent EP 2853538 A1

Sequence  FLKGIVGMLGKLL

Sequence Length  13

UniProt ID  B3KYH4 

PubChem CID  Not available

Origin  Synthetic (Derived from Temporin-1Sa)

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
THP-1 Childhood acute monocytic leukemia; Acute monoblastic/monocytic leukemia Leukemia Not determined MTT assay 72 h Patent
HepG2 Hepatoblastoma Blastoma LC50=376 μM MTT assay 72 h Patent

Hemolytic Activity  Rat erythrocytes: LC50=45 µM

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial; Antifungal



Structure Information


PDB ID  Not available

Predicted Structure  DRACP02404

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C67H117N15O14S

Absent amino acids  ACDEHNPQRSTWY

Common amino acids  L

Mass  160306

Pl  10.81

Basic residues  2

Acidic residues  0

Hydrophobic residues  7

Net charge  2

Boman Index  2569

Hydrophobicity  150.77

Aliphatic Index  172.31

Half Life 
  Mammalian: 1.1 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  3

Amino acid distribution



Literature Information


Literature 1

Pubmed ID Not available

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID EP 2853538 A1

Patent Title  Analogues of temporin-SHa and uses thereof

Other Iinformation  Patent Application; Family: 11s / 11ex; Family Jurisdictions: CA, EP, JP, BR, US, WO, ES; Legal Status: Discontinued; Application No: 13306344; Filed: Sep 27, 2013; Published: Apr 1, 2015; Earliest Priority: Sep 27, 2013

Other Published ID  BR112016006424A2  CA2924035A1  EP3049432A1  EP3049432B1  ES2691323T3  JP2016539658A  JP6669656B2  US2016280749A1  US9932376B2  WO2015044356A1 




DBAASP ID  DBAASPS_9111

DRACP is developed by Dr.Zheng's team.